Get the Stockscreener App
32.25
1.67%
0.53
After Hours:
32.46
0.21
+0.65%
Royalty Pharma Plc Stock (RPRX) Latest News
Royalty Pharma’s Optimistic Earnings Call Highlights Growth - TipRanks
Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts - MSN
Royalty Pharma earnings missed by $0.63, revenue fell short of estimates - Investing.com South Africa
Earnings call transcript: Royalty Pharma Q4 2024 misses EPS forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Royalty Pharma Q4 2024 misses EPS forecast - Investing.com
Royalty Pharma (NASDAQ:RPRX) Posts Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat
Royalty Pharma (RPRX) Reports Q4 Revenue of $594 million - StreetInsider.com
Royalty Pharma reports Q4 portfolio receipts of $742M - TipRanks
Royalty Pharma Q4 Net Income, Revenue Decrease -February 11, 2025 at 07:41 am EST - Marketscreener.com
Earnings Flash (RPRX) Royalty Pharma Reports Q4 Revenue $594M, vs. FactSet Est of $687.1M - Marketscreener.com
Royalty Pharma's Triple Win: 12% Revenue Jump, Massive Buyback, and Strategic Acquisition - StockTitan
abrdn plc Has $2.28 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma: Q4 Earnings Snapshot -February 11, 2025 at 07:31 am EST - Marketscreener.com
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Lecap Asset Management Ltd. - MarketBeat
Paragon Capital Management Inc. Buys 53,937 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Where are the Opportunities in (RPRX) - Stock Traders Daily
Royalty Pharma (RPRX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Inlet Private Wealth LLC Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Lifted by China Universal Asset Management Co. Ltd. - MarketBeat
BlackRock, Inc.'s Strategic Acquisition of Royalty Pharma PLC Sh - GuruFocus.com
Mediolanum International Funds Ltd Has $3.55 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Manning & Napier Advisors LLC - MarketBeat
Kearns & Associates LLC Makes New $451,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Swedbank AB Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Royalty Pharma completes sale of MorphoSys bonds - MSN
Royalty Pharma stock gains on MorphoSys bonds sale (RPRX) - Seeking Alpha
Royalty Pharma (RPRX) Announces Sale of MorphoSys Development Funding Bonds - StreetInsider.com
Royalty Pharma Closes Sale of MorphoSys Development Funding Bonds -January 29, 2025 at 09:40 am EST - Marketscreener.com
Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds - EIN News
Subdued Growth No Barrier To Royalty Pharma plc (NASDAQ:RPRX) With Shares Advancing 25% - Simply Wall St
Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 - Marketscreener.com
Trend Tracker for (RPRX) - Stock Traders Daily
Royalty Pharma Earnings: Strategic Timing Ahead of Market Open Reveals Key Financial Insights - StockTitan
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week HighWhat's Next? - MarketBeat
1834 Investment Advisors Co. Buys Shares of 9,500 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Assenagon Asset Management S.A. Purchases Shares of 19,068 Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Assenagon Asset Management S.A. Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Impact Partnership Wealth LLC Purchases Shares of 18,323 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now? - Insider Monkey
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst - Benzinga
Wall Street Analysts Predict a 31.15% Upside in Royalty Pharma (RPRX): Here's What You Should Know - Yahoo Finance
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):